EBioMedicine

eBioMedicine is a peer-reviewed open access medical journal initially launched by Elsevier, shortly thereafter supported by Cell Press and The Lancet, and in 2018 incorporated in The Lancet family journals, at the occasion of the inception of its sister journal eClinicalMedicine (Impact Factor 9.6), also published by The Lancet.^[1] In January 2022, eBioMedicine and eClinicalMedicine became parts of THE LANCET Discovery Science, a suite of open access journals dedicated to essential early evidence.^[2]

eBioMedicine

Discipline	Medicine
Language	English
Publication details
History	2014-present
Publisher	Elsevier
Frequency	Continuous
Open access	Yes
Impact factor	9.7 (2023)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	eBioMedicine
Indexing CODEN (alt) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus · W&L
ISSN	2352-3964
Links
Journal homepage

The journal is abstracted and indexed in Index Medicus, MEDLINE, and PubMed.^[3]